This paper is only available as a PDF. To read, Please Download here.
The pharmacokinetics and pharmacodynamics of testosterone trans-4-n-butylcyclohexyl carboxylate (Code name: 20 Aet-1), a new long-acting androgen ester, were evaluated in castrated adult rhesus monkeys and compared with those of testosterone enanthate (TE). A single intramuscular injection of 40 mg of 20 Aet-1 returned serum testosterone (T) to within or close to the diurnal physiological range for 80–136 days. In contrast, a similar dose of TE increased serum T to supraphysiological levels and the response evoked was of short duration. The ratio of T to dihydrotestosterone (T/DHT) ratio in monkeys treated with 20 Aet-1 was comparable to that found in control animals while in TE-treated animals, it was highly elevated. Serum estradiol (E2) elevation by 20 Aet-1 was also of smaller magnitude compared to TE. 20-Aet-1 suppressed LH levels from day 5 until day 115. The levels of LH on day 115 were 45.8% lower compared to the levels on day 13 post-castration. TE suppressed LH levels from day 1–7 post-injection. The values on day 7 were 76.6% lower compared to values on day 13 post-castration. Thus, TE-induced suppression of LH was of shorter duration, but of greater magnitude compared to the effect caused by 20 Aet-1. Similarly, FSH was suppressed for a longer duration (days 21–74) by 20 Aet-1 than by TE. The results indicate that the new testosterone ester has highly favourable pharmaco-kinetic properties and may prove to be the androgen of choice for supplementation therapy in contraceptive regimens.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Contraception
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Regulation of male fertility.in: Diczfalusy E. Diczfalusy A. 8 Aufl. Research on the Regulation of Human Fertility. Vol.2. 1983: 729-767 (Copenhagen)
- Bioavailability and LH suppressing effect of different testosterone preparations in normal and hypogonadal men.Hormone Res. 1976; 7: 138-145
- Comparison of kinetics of injectable testosterone in eugonadal and hypogonadal men.Fertil Steril. 1982; 37: 425-430
- Comparison of testosterone, dihydrotestosterone, luteinisng hormone and follicle stimulating hormone in serum after injection of testosterone enanthate or testosterone cypionate.Fertil Steril. 1980; 33: 201-203
- Comparative pharmaco-kinetics of testosterone enanthate and testosterone cyclohexane-carboxylate as assessed by serum and saliva testosterone in normal men.Int J Androl. 1984; 7: 181-187
Bialy, G. Personal Communication (1985).
- New injectable testosterone ester maintains serum testosterone of castrated monkeys in the normal range for four months.Acta Endocrinol. 1986; 113: 128-132
- Programme for the Provision of Matched Assay Reagents for the Radioimmunoassay of Hormones in Reproductive Physiology.1986
- Circadian variations in systemic hormone levels in healthy men.J Endocrinol Invest. 1979; 2: 131-137
- Radioimmunoassay of six steroids in human plasma.Steroids. 1973; 22: 775-794
- Biological and immunological characterisation of purified follicle stimulating hormone preparations from monkey pituitaries.J Med Primatol. 1984; 13: 269-282
- Hetero-logous radioimmunoassay of monkey luteinising hormone. A critical assessment.J Med Primatol. 1984; 13: 191-204
Accepted: June 16, 1989
Received: December 2, 1988
© 1989 Published by Elsevier Inc.